Dyadic International, Inc. (DYAI) vs Marker Therapeutics, Inc. (MRKR)
A side-by-side comparison of Dyadic International, Inc. and Marker Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DYAI
Dyadic International, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 11:29 AM EDT
MRKR
Marker Therapeutics, Inc.
$1.04HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT
Total return — DYAI vs MRKR
growth of $100 · dividends reinvested · last 10yDYAI -70.5% (-11.5%/yr)MRKR -98.3% (-33.4%/yr)DYAI compounded faster over this window
Log scale — wide-divergence pair
DYAI MRKR
DYAI vs MRKR: by the numbers
- •MRKR is the larger company ($17M vs $17M market cap).
- •Both run net losses; DYAI's is the smaller (-219.50% vs -706.23% net margin).
Metrics side by side
Valuation
| Metric | DYAI | MRKR |
|---|---|---|
| P/S ratio | 4.77 | 14.06 |
| P/B ratio | N/A | 1.43 |
Profitability
| Metric | DYAI | MRKR |
|---|---|---|
| Gross margin | -88.25% | 0.00% |
| Operating margin | -579.88% | 0.00% |
| Net margin | -219.50% | -706.23% |
| ROE | N/A | -71.57% |
| ROIC | -279.48% | -88.07% |
Growth (annualized)
| Metric | DYAI | MRKR |
|---|---|---|
| Revenue CAGR (5Y) | -5.11% | N/A |
| Total return CAGR (5Y) | -38.53% | -42.13% |
Frequently asked
- How have DYAI and MRKR total returns compared?
- Over the past 10 years, DYAI delivered -11.56% and MRKR delivered -33.25% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.